[Visceral and cutaneous Kaposi sarcoma in a patient with rheumatoid arthritis under steroid treatment].
We present the case of a patient under corticosteroid therapy (Deflazacort) developing a cutaneous Kaposi's Sarcoma. In a latter study performed due to the presence of digestive syndrome, a gastric Kaposi's sarcoma was detected. We review the cases published in the literature of patients with rheumatoid pathology under corticosteroid therapy.
Hortelano Martínez
E
E
Sección de Reumatología y Osteoporosis, Hospital General Universitario de Valencia.
Calvo Catalá
J
J
Liñana Santafé
J J
JJ
González-Cruz
M I
MI
Soler Ros
J J
JJ
Fontbuena Moreno
M
M
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D011282:Pregnenediones / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000150:complications*; D013274:Stomach Neoplasms / Q000150:complications*
D000893:Anti-Inflammatory Agents; D011282:Pregnenediones; C021988:deflazacort
Sarcoma de Kaposi visceral y cutáneo en paciente con artritis reumatoide en tratamiento esteroideo.